Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle

NCT: NCT06696118 · ACTIVE_NOT_RECRUITING

NCT IDNCT06696118
StatusACTIVE_NOT_RECRUITING
Start Date2025-03-13
Completion2027-01

Brief Summary

The purpose of this study is to determine if Electromagnetic Transduction Therapy (EMTT) is a viable treatment option in patients with osteoarthritis of the foot and/or ankle.

Frequently Asked Questions

What is Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle?

Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle is a clinical trial registered under NCT06696118. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06696118?

The current status of NCT06696118 (Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle) is: ACTIVE_NOT_RECRUITING.

When did Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle start?

Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle started on 2025-03-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑